SCHEMBL25016481

SCHEMBL25016481

CC(C)(C)c1nc(I)c2c(n1)oc1ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ LMNA P02545 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.36
▸ HPGD P15428 3/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ DUSP3 P51452 1/20 0.36
▸ PTPN5 P54829 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PTPN11 Q06124 1/20 0.36
▸ EGFR P00533 5/20 0.36
▸ IGF1R P08069 5/20 0.36
▸ FLT4 P35916 4/20 0.36
▸ KDR P35968 4/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24627141 0.83 SMN1; SMN2 (0.39) SMN1; SMN2LMNAALDH1A1HPGDL3MBTL1
SCHEMBL19162424 0.83 SMN1; SMN2 (0.42) SMN1; SMN2LMNAALDH1A1HPGDL3MBTL1
SCHEMBL24807090 0.81 LMNA (0.43) SMN1; SMN2LMNAALDH1A1HPGDL3MBTL1
SCHEMBL19161626 0.79 MEN1 (0.42) SMN1; SMN2LMNAALDH1A1HPGDL3MBTL1
SCHEMBL25016630 0.77 SMN1; SMN2 (0.37) SMN1; SMN2LMNAALDH1A1HPGDL3MBTL1
SCHEMBL19162692 0.77 MEN1 (0.40) SMN1; SMN2LMNAALDH1A1HPGDL3MBTL1
SCHEMBL19161278 0.76 SMN1; SMN2 (0.40) SMN1; SMN2LMNAALDH1A1HPGDL3MBTL1
SCHEMBL25878062 0.76 ALDH1A1 (0.41) SMN1; SMN2LMNAALDH1A1HPGDL3MBTL1
SCHEMBL23473799 0.74 PLA2G2A (0.37) SMN1; SMN2LMNAALDH1A1HPGDL3MBTL1
SCHEMBL19161198 0.74 CYP1A2 (0.36) SMN1; SMN2LMNAALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2023-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same CYBA, SUN2, TMEM109 SMN1; SMN2 4044/4885LMNA 1562/4885ALDH1A1 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback